Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Foy

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 13, 2022
Prediction of large-for-gestational-age infant by fetal growth charts and hemoglobin A1c level in pregnancy complicated by pregestational diabetesM K Kiefer, M M Finneran, C A Ware, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2016
Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cellsSusan P Foy, Stefanie J Mandl, Tracy dela Cruz, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Mechanism of B cell antigen receptor function: transmembrane signaling and triggering of apoptosisA L DeFranco, P R Mittelstadt, J H Blum, et al.
Annals of the New York Academy of Sciences|September 7, 1995
Signal transduction by the B-cell antigen receptorA L DeFranco, J D Richards, J H Blum, et al.
Optics Express|July 8, 2009
Silicon optical fiberJ Ballato, T Hawkins, P Foy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockadeJ-P Foy, C Bertolus, M-C Michallet, et al.
Nature|November 10, 2022
Non-viral precision T cell receptor replacement for personalized cell therapySusan P Foy, Kyle Jacoby, Daniela A Bota, et al.
Nature|March 8, 2023
Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapyCristina Puig-Saus, Barbara Sennino, Songming Peng, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|September 13, 2022
Prediction of large-for-gestational-age infant by fetal growth charts and hemoglobin A1c level in pregnancy complicated by pregestational diabetesM K Kiefer, M M Finneran, C A Ware, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2016
Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cellsSusan P Foy, Stefanie J Mandl, Tracy dela Cruz, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Mechanism of B cell antigen receptor function: transmembrane signaling and triggering of apoptosisA L DeFranco, P R Mittelstadt, J H Blum, et al.
Annals of the New York Academy of Sciences|September 7, 1995
Signal transduction by the B-cell antigen receptorA L DeFranco, J D Richards, J H Blum, et al.
Optics Express|July 8, 2009
Silicon optical fiberJ Ballato, T Hawkins, P Foy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 2, 2017
The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockadeJ-P Foy, C Bertolus, M-C Michallet, et al.
Nature|November 10, 2022
Non-viral precision T cell receptor replacement for personalized cell therapySusan P Foy, Kyle Jacoby, Daniela A Bota, et al.
Nature|March 8, 2023
Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapyCristina Puig-Saus, Barbara Sennino, Songming Peng, et al.
Pageof 7